Covered recipient · General Payments record
SHAYLAH MILLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2022–2024
$1,241.64
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.08 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $318.65 | 19 |
| Lilly USA, LLC | $96.92 | 4 |
| Acerta Pharma LLC | $46.50 | 2 |
| Novo Nordisk AS | $45.74 | 2 |
| E.R. Squibb & Sons, L.L.C. | $42.00 | 2 |
| Sumitomo Pharma America, Inc. | $39.83 | 2 |
| Exact Sciences Corporation | $24.99 | 1 |
| SHIELD THERAPEUTICS INC | $23.86 | 1 |
| Astellas Pharma US Inc | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $13.59 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520073 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.47 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105466583 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.03 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104481770 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.29 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101833177 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.71 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101833206 | CMS |
| Exact Sciences Corporation | $24.99 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114790195 | CMS |
| Lilly USA, LLC | $25.22 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135938422 | CMS |
| Lilly USA, LLC | $21.20 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939184 | CMS |
| Lilly USA, LLC | $30.41 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135865061 | CMS |
| Lilly USA, LLC | $20.09 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939186 | CMS |
| Novo Nordisk Inc | $20.56 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100368367 | CMS |
| Novo Nordisk Inc | $25.18 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100543032 | CMS |
| PFIZER INC. | $9.71 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131550703 | CMS |
| PFIZER INC. | $17.36 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130980628 | CMS |
| PFIZER INC. | $7.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131550700 | CMS |
| PFIZER INC. | $19.09 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131018147 | CMS |
| PFIZER INC. | $12.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131469084 | CMS |
| PFIZER INC. | $14.29 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131261957 | CMS |
| PFIZER INC. | $14.27 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131379244 | CMS |
| PFIZER INC. | $17.70 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131384364 | CMS |
| PFIZER INC. | $22.42 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131456636 | CMS |
| PFIZER INC. | $8.55 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131436397 | CMS |
| PFIZER INC. | $18.77 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131690683 | CMS |
| PFIZER INC. | $7.99 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131653180 | CMS |
| PFIZER INC. | $22.47 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131740768 | CMS |
| PFIZER INC. | $10.04 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743092 | CMS |
| PFIZER INC. | $24.88 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131862131 | CMS |
| PFIZER INC. | $23.37 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131963468 | CMS |
| PFIZER INC. | $21.26 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132123533 | CMS |
| PFIZER INC. | $23.93 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131006094 | CMS |
| PFIZER INC. | $22.05 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131081193 | CMS |
| SHIELD THERAPEUTICS INC | $23.86 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150122335 | CMS |
| Sumitomo Pharma America, Inc. | $18.84 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148981675 | CMS |
| Sumitomo Pharma America, Inc. | $20.99 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148981677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.